AGP Executive Report
Last update: an hour agoDementia Care Breakthrough: A federally funded, placebo-controlled trial found a THC/CBD combo (2mg THC + 100mg CBD) significantly reduced agitation in 84% of dementia patients by week two and 87% by the end of a 12-week study, with caregiver-rated improvements far higher than placebo. Hemp & CBD Product Watch: THC drinks face a federal deadline on Nov. 12, 2026, when the hemp definition tightens—consumer products over 0.4mg total THC per container could be pulled from the legal hemp market and treated as marijuana. Medical Cannabis Access: Moab, Utah’s first medical cannabis pharmacy is expected to open this fall after renovations and final state steps, with the nearest licensed option currently about two hours away. Legal/Policy Ripple: The Supreme Court’s Hemani ruling blocks firearm possession bans tied to marijuana use, but old drug convictions may still affect licensing for certain jobs. Public Safety/Health Context: Guyana’s MV Barima ferry disaster continues, with authorities citing an unreliable passenger manifest and crew drug-use concerns—raising questions about accountability as search and rescue goes on.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
